Every deal should start where the last one finished.
How can serial acquirers run more deals without more people?
Serial acquirers run more deals without adding people by keeping one living record per target and carrying research forward between deals. Reuben AI researches each target, tests claims against outside evidence, keeps findings current and records each decision, so market and competitor work from one deal starts the next instead of being rebuilt.
The problem today
- Each bolt-on repeats market and competitor work already done.
- Lessons from past integrations sit in old files nobody opens.
- Pipeline volume outgrows the size of the deal team.
How Reuben AI helps
Research that compounds. Market, competitor and sector findings carry forward to the next target.
Consistent screening. Every target is tested against the same saved acquisition criteria.
A record of past decisions. See why earlier targets were approved or stopped.
Less rework. The team spends time on judgement, not on rebuilding the same pack.
Why serial acquirers lose time between deals
Most acquisition teams store each deal in its own folder. When the next target appears in the same sector, the research starts again from a blank page. A living record keeps that work in one place and keeps it current, so the team builds on it.
What to keep from every deal
- Market and competitor findings, with where each came from
- The criteria the target was tested against
- Deal-stopping issues found, and how they were resolved
- Why the deal was approved or stopped
What you get
- Target profiles
- Screening summaries
- Diligence findings
- Steering committee packs
Security and trust
- Client data is isolated, with access control and an audit trail on every record.
- Data residency is available in APAC, EMEA or the Americas.
- Every finding is fully sourced and marked verified or cross-checked.
- People make the decisions. Reuben AI does not give investment advice.